| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Hyunsu Jung | Chief Executive Officer and Chief Investment Officer | 2026-06-02 | 500 | $3.64 | $1.82kBuy |
| Hyunsu Jung | Chief Executive Officer and Chief Investment Officer | 2026-06-02 | 500 | $3.68 | $1.84kBuy |
| Hyunsu Jung | Chief Executive Officer and Chief Investment Officer | 2026-06-01 | 5,000 | $3.66 | $18.30kBuy |
| Hyunsu Jung | Chief Executive Officer and Chief Investment Officer | 2026-06-01 | 2,000 | $3.81 | $7.62kBuy |
| David R. Knox | Chief Financial Officer | 2025-12-31 | 27,950 | $3.59 | $100.34kBuy |
| Ellen R. Strahlman | Director | 2025-12-29 | 12,112 | $3.60 | $43.60kBuy |
| Ellen R. Strahlman | Director | 2025-12-29 | 11,856 | $3.61 | $42.80kBuy |
| Ellen R. Strahlman | Director | 2025-12-26 | 3,601 | $3.86 | $13.91kBuy |
| Ellen R. Strahlman | Director | 2025-12-26 | 3,311 | $3.86 | $12.78kBuy |
| Ellen R. Strahlman | Director | 2025-12-18 | 19,702 | $3.14 | $61.84kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Stuart M. Grant | 72.00% | 10,914,153 | $34.27M | Insider |
| Shuhei Yoshida | 11.56% | 1,751,900 | $5.50M | Insider |
| Senju Pharmaceutical Co Ltd | 11.34% | 1,718,566 | $5.40M | Insider |
| Fredric N. Eshelman | 10.68% | 1,618,835 | $5.08M | Insider |
| Hyunsu Jung | 9.14% | 1,385,676 | $4.35M | Insider |
| Curt H. Labelle | 4.28% | 648,903 | $2.04M | Insider |
| Ernest Mario | 2.52% | 382,706 | $1.20M | Insider |
| David R. Knox | 2.03% | 307,119 | $964.35k | Insider |
| Morgan Stanley | 1.57% | 237,986 | $747.28k | Institution |
| Ellen R. Strahlman | 1.22% | 184,947 | $580.73k | Insider |